fgfr
No description yet: the sentence for this tag has not been written. 2 records carry it: 2 biomarkers.
Related tags
2 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
FGFR2 fusion or rearrangement FGFR2 FGFR2 fusions occur in 10 to 15 percent of intrahepatic bile duct cancers and almost nowhere else. Pemigatinib and futibatinib are approved for them after a first chemotherapy. | Biliary tract cancer, Intrahepatic cholangiocarcinoma, Biliary tract cancer | none | biomarker | ||
FGFR3 alteration (mutation or fusion) FGFR3 FGFR3 point mutations and TACC3 fusions drive about 15 to 20 percent of advanced bladder cancers. Erdafitinib is approved for tumours with these 'susceptible' alterations after one prior treatment. | Bladder & urothelial cancer | none | biomarker |